Hébert: It's time to stop pharma-driven 'free lunch' approach

Share this article:
The Canadian Medical Association Journal ran an editorial excoriating industry-funded education, which editor-in-chief Dr. Paul Hébert said “embellishes the positive elements of studies and downplays the adverse effects.” “It is time to stop the pharma-driven ‘free-lunch' approach” Hébert concluded.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.